Status:
UNKNOWN
Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
Lead Sponsor:
Southern Medical University, China
Conditions:
Laryngeal Neoplasms
Pharyngeal Neoplasms
Eligibility:
All Genders
15-75 years
Brief Summary
The aim of the study is to find for one or more serum or tissue markers of molecular biology in head and neck cancer patients used for early diagnosis, predicting prognosis and being sensitive to chem...
Detailed Description
Head and neck malignant tumors, especially nasopharyngeal carcinoma in southern China with the high incidence, its incidence, treatment, prognosis or tumor markers in serum has been a hot research wit...
Eligibility Criteria
Inclusion
- all of nasopharyngeal carcinoma
- hypopharyngeal carcinoma or laryngeal carcinoma visited at ENT department of NanFang hospital
Exclusion
- all of above patients whose anticipated survival duration were less than 6 months
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01171235
Start Date
July 1 2010
End Date
December 1 2012
Last Update
July 28 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.